How do German General Practitioners Manage Long-/Post-COVID? A Qualitative Study in Primary Care

被引:11
作者
Bachmeier, Beatrice E. [1 ]
Hoelzle, Salome [1 ]
Gasser, Mohamed [1 ]
van den Akker, Marjan [2 ,3 ,4 ]
机构
[1] Goethe Univ, Inst Pharmaceut Biol, D-60438 Frankfurt, Germany
[2] Goethe Univ, Inst Gen Practice, D-60590 Frankfurt, Germany
[3] Maastricht Univ, Care & Publ Hlth Res Inst, Dept Family Med, NL-6229 ER Maastricht, Netherlands
[4] Katholieke Univ Leuven, Acad Ctr Gen Practice, Dept Publ Hlth & Primary Care, B-3000 Leuven, Belgium
来源
VIRUSES-BASEL | 2023年 / 15卷 / 04期
关键词
Long-; Post-COVID; qualitative study; primary care;
D O I
10.3390/v15041016
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Many patients with ongoing complaints after a SARS-CoV-2 infection are treated in primary care. Existing medical guidelines on how to diagnose and treat Long-/Post-COVID are far from being comprehensive. This study aims to describe how German general practitioners (GPs) deal with this situation, what problems they experience when managing such patients, and how they solve problems associated with the diagnosis and treatment of Long-/Post-COVID. Methods and Findings: We conducted a qualitative study and interviewed 11 GPs. The most commonly described symptoms were ongoing fatigue, dyspnea, chest tightness and a decrease in physical capacity. The most common way to identify Long-/Post-COVID was by exclusion. Patients suffering from Long-/Post-COVID were generally treated by their GPs and rarely referred. A very common non-pharmacological intervention was to take a wait-and-see approach and grant sick leave. Other non-pharmacological interventions included lifestyle advices, physical exercise, acupuncture and exercises with intense aromas. Pharmacological treatments focused on symptoms, like respiratory symptoms or headaches. Our study's main limitations are the small sample size and therefore limited generalizability of results. Conclusions: Further research is required to develop and test pharmaceutical and non-pharmaceutical interventions for patients with Long-/Post-COVID. In addition, strategies to prevent the occurrence of Long-/Post-COVID after an acute infection with SARS-CoV-2 have to be developed. The routine collection of data on the diagnosis and management of Long-/Post-COVID may help in the formulation of best practices. It is up to policymakers to facilitate the necessary implementation of effective interventions in order to limit the huge societal consequences of large groups of patients suffering from Long-/Post-COVID.
引用
收藏
页数:14
相关论文
共 25 条
  • [1] 'I don't know what to do or where to go'. Experiences of accessing healthcare support from the perspectives of people living with Long Covid and healthcare professionals: A qualitative study in Bradford, UK
    Baz, Sarah A.
    Fang, Chao
    Carpentieri, J. D.
    Sheard, Laura
    [J]. HEALTH EXPECTATIONS, 2023, 26 (01) : 542 - 554
  • [2] Two-Year Prevalence and Recovery Rate of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19
    Boscolo-Rizzo, Paolo
    Fabbris, Cristoforo
    Polesel, Jerry
    Emanuelli, Enzo
    Tirelli, Giancarlo
    Spinato, Giacomo
    Hopkins, Claire
    [J]. JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2022, 148 (09) : 889 - 891
  • [3] Brennan A, 2022, IRISH J MED SCI, V191, pS48
  • [4] How and why patients made Long Covid
    Callard, Felicity
    Perego, Elisa
    [J]. SOCIAL SCIENCE & MEDICINE, 2021, 268
  • [5] Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review
    Chen, Chen
    Haupert, Spencer R.
    Zimmermann, Lauren
    Shi, Xu
    Fritsche, Lars G.
    Mukherjee, Bhramar
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (09) : 1593 - 1607
  • [6] A Brief Questionnaire to Assess Post-Exertional Malaise
    Cotler, Joseph
    Holtzman, Carly
    Dudun, Catherine
    Jason, Leonard A.
    [J]. DIAGNOSTICS, 2018, 8 (03):
  • [7] Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer
    Cramer, Holger
    Lauche, Romy
    Klose, Petra
    Lange, Silke
    Langhorst, Jost
    Dobos, Gustav J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (01):
  • [8] COVID-19: persistence of symptoms and lung alterations after 3-6 months from hospital discharge
    Fortini, Alberto
    Torrigiani, Arianna
    Sbaragli, Serena
    Lo Forte, Aldo
    Crociani, Andrea
    Cecchini, Paolo
    Innocenti Bruni, Giulia
    Faraone, Antonio
    [J]. INFECTION, 2021, 49 (05) : 1007 - 1015
  • [9] Zatwierdzone przez: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
    Galie, Nazzareno
    Humbert, Marc
    Vachiery, Jean-Luc
    Gibbs, Simon
    Lang, Irene
    Torbicki, Adam
    Simonneau, Gerald
    Peacock, Andrew
    Noordegraaf, Anton Vonk
    Beghetti, Maurice
    Ghofrani, Ardeschir
    Gomez Sanchez, Miguel Angel
    Hansmann, Georg
    Klepetko, Walter
    Lancellotti, Patrizio
    Matucci, Marco
    McDonagh, Theresa
    Pierard, Luc A.
    Trindade, Pedro T.
    Zompatori, Maurizio
    Hoeper, Marius
    [J]. KARDIOLOGIA POLSKA, 2015, 73 (12) : 1127 - 1206
  • [10] Gebru Addis Adera, 2021, Human Antibodies, V29, P139, DOI 10.3233/HAB-200420